You are here
ABREOS BIOSCIENCES, INC.
UEI: KM24BL6J7XG3
# of Employees: N/A
HUBZone Owned: No
Socially and Economically Disadvantaged: No
Woman Owned: No
Award Charts
Award Listing
-
Personalized precision dosing of anti-TNF biologic therapies
Amount: $1,582,190.00Biologics are increasingly used in the treatment of autoimmune and inflammatory diseases. Monoclonal antibody (mAb) drugs that target tumor necrosis factor alpha (TNF-a), such as Remicade (infliximab) ...
SBIRPhase II2019Department of Health and Human Services National Institutes of Health -
Personalized precision dosing of anti-TNF biologic therapies
Amount: $298,851.00Project SummaryBiologics are increasingly used in the treatment of autoimmune and inflammatory diseasesMonoclonal antibodymAbdrugs that target tumor necrosis factor alphaTNF asuch as Remicadeinflixima ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Affinity Purification of Biologics with Mimetope Peptides
Amount: $217,898.00Monoclonal antibodies and other biologicsincluding next generation antibody therapeuticsare the fastest growing segment of the pharmaceutical industryprojected to reach almostB in annual sales byBiolo ...
SBIRPhase I2018Department of Health and Human Services National Institutes of Health -
Personalized precision dosing of biologic therapies in oncology
Amount: $1,481,626.00AbstractRituximabisamonoclonalantibodymAbamongthetopbestsellingdrugswithglobalsalesestimatedtoexceed$ BinRituximabisindicatedtotreatconditionsincludingchroniclymphocyticleukemiaCLLBcellnonHodgkinandap ...
SBIRPhase II2017Department of Health and Human Services National Institutes of Health -
Novel Materials for Viral Purification
Amount: $224,166.00Abstract Viruses have significant commercial application as vectors for gene and cell therapy as well as vaccines for cancer treatment and infectious diseases The purification of commercial viruses ...
SBIRPhase I2017Department of Health and Human Services National Institutes of Health -
Cleavage Coupled Lateral Flow Immunoassay for Rapid Endotoxin Testing
Amount: $214,428.00DESCRIPTION provided by applicant Bacterial endotoxins namely lipopolysaccharide LPS are common contaminants of many pharmaceutical medical device and food products that can elicit very stron ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Multiplexed DeNAno Protein Assay and Quantitation: Sequencing Based Proteomics
Amount: $225,000.00DESCRIPTION provided by applicant Proteomics studies have the power to deliver pivotal new insight into cancer cells biomarkers and host responses Unlike genomics however the field of proteom ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Activin A antagonist for treatment of cancer-associated cachexia
Amount: $225,000.00DESCRIPTION provided by applicant Cachexia is a major cause of suffering and death among patients with late stage cancers and the current treatment options are limited and ineffective We have iden ...
SBIRPhase I2015Department of Health and Human Services National Institutes of Health -
Novel Activin A Antagonists for Treatment of Osteoporosis
Amount: $224,811.00DESCRIPTION provided by applicant Bone loss and fragility from osteoporosis afflict more than million people worldwide including at least million Americans Current osteoporosis treatments ...
STTRPhase I2015Department of Health and Human Services National Institutes of Health -
Lateral Flow Immunoassay for Therapeutic Monoclonal Antibody Quality Assurance
Amount: $172,406.00DESCRIPTION (provided by applicant): Monoclonal antibodies (mAb) are valuable therapeutics for treating cancer and other diseases, but their high cost makes them attractive targets for counterfeiting ...
SBIRPhase I2014Department of Health and Human Services National Institutes of Health
